Average Co-Inventor Count = 2.46
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Regeneron Pharmaceuticals, Inc. (9 from 1,343 patents)
2. New York University (1 from 1,627 patents)
10 patents:
1. 11655291 - Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
2. 10526403 - Anti-activin A antibodies and uses thereof
3. 10400036 - Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
4. 9890212 - Antibodies to human GDF8
5. 9718881 - Anti-Activin A antibodies and uses thereof
6. 9260515 - Antibodies to human GDF8
7. 8871209 - Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A
8. 8840894 - Antibodies to human GDF8
9. 7632503 - Method of treating a muscle-related condition with modified IGF1 polypeptides
10. 6720181 - Ubiquitin ligases as therapeutic targets